Isoxepac

HCID 41448CAS 55453-87-7

Grundinformationen

Standard-SMILES
O=C(O)Cc1ccc2c(c1)C(=O)c1ccccc1CO2
InChIKey
QFGMXJOBTNZHEL-UHFFFAOYSA-N
Summenformel
C16H12O4
Durchschnittliche Molmasse
268,26 g/mol
Monoisotopische Masse
268,07355886

Überblick

Isoxepac is a dibenzooxazepine.

Namen und Bezeichner

Bevorzugter Name
Isoxepac
IUPAC
2-(11-oxo-6H-benzo[c][1]benzoxepin-2-yl)acetic acid
Englischer Name
Isoxepac
Summenformel
C16H12O4
Molmasse
268.26

Namen und Synonyme

Isoxepac55453-87-7ArtilHP 549IsoxepacumHP-549P 7205496,11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acidIsoxepacoDTXSID8057772NSC-3009072KH283Q0Z5
Weitere Namen anzeigen
OlapatadineOlopatadine Related CoMpound C6,11-Dihydro-11-oxodibenzo[b,e]oxepin-2-acetic Acidhp549ND4-B2
Dibenz[b,e]oxepin-2-acetic acid, 6,11-dihydro-11-oxo-P-7205496,11-Dihydro-11-oxodibenz(b,e)oxepin-2-acetic acidDTXCID9031561DIBENZ(b,e)OXEPIN-2-ACETIC ACID, 6,11-DIHYDRO-11-OXO-RefChem:7924562-(11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid

Datenbank-Bezeichner

CAS
55453-87-7
PubChem CID
41448
DTXSID
DTXSID8057772
ChEMBL
CHEMBL33211
ChEBI
CHEBI:135102
UNII
2KH283Q0Z5
EC Number
611-268-9
Nikkaji
J11.446D

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,4
Polarare Oberfläche (TPSA)
63,6 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
2
Schwere Atome
20

Physikochemische Eigenschaften

Schmelzpunkt
130 · 130-132°C
Siedepunkt
528.2 · 528.2±50.0 °C(Predicted)
Dichte
1.39 g/cm3 · 1.39 g/cm3
storage temp.
Sealed in dry,Room Temperature
Löslichkeit
soluble in Methanol
pka
4.24 · 4.24±0.10(Predicted)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (85.7%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 7 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 3 (85.7%)

Sicherheitsdaten

wgk
WGK 3
ridadr
UN 2811 6.1 / PGIII
hs_code
2932996560
RTECS-Nr.
HQ4110000
risk_code
25-62
Toxizität
LD50 orally in rats: 199 mg/kg (Ueno)

Chemie und Industrie

Anwendungen · 1 Eintrag

VerwendenIsoxepac is a non-steroidal anti-inflammatory with analgesic and antipyretic activity. It is more slowly absorbed and eliminated in the rat and rabbit after oral dosing than in the dog, rhesus monkey and man.It can be used to treat allergic rhinitis, urticaria, and skin diseases with itching symptoms.

Darstellung · 1 Eintrag

synthetischeIsoxic acid is an important intermediate in the synthesis of the new preferred anti-allergic drug, olopatadine hydrochloride, preparation method of isoxepac:(1) condensation: prepare p-hydroxyphenylaceticacid 8-12 part, phthalide 6-12 part, sodium methylate 8-12 part by weight; Dissolve with DMAC and to add said sodium methylate behind said p-hydroxyphenylaceticacid and the phthalide; Be that 0.1-10Pa is heated to 80-170 ℃ of reaction 3-10h at pressure then; Regulate the pH value to 1-5,4-(2-carboxyl benzyloxy) toluylic acid is separated out in crystallization;(2) cyclization: with Glacial acetic acid min. 99.5 dissolving step (1) gained 4-(2-carboxyl benzyloxy) toluylic acid, adding 3-52 weight part polyphosphoric acid again, is that 0.1-10Pa is heated to 30-100 ℃ of reaction 3-12h at pressure, and crystallisation by cooling gets the Isoxepac bullion then;(3) purify: behind the said Isoxepac bullion of acetic acid ethyl dissolution, refining decolouring gets the Isoxepac product.https://patents.google.com/patent/CN102838582A/en

Anbieter50 Anbieter

梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
INTATRADE GmbH+49 3493/605464 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]
北京安司莫森技术有限公司010-82954736 13391601435 · [email protected]

Ergänzende Hinweise

DefinitionChEBI: Isoxepac is a dibenzooxazepine.

Zugehörige Reaktionen

1.912

Verknüpfte Notizen

Wird geladen…